SCHEMBL27508457

SCHEMBL27508457

CC(=O)OC1(N)CCCC(C)C1C

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 1/20 0.33
▸ EP300 Q09472 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ CREBBP Q92793 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28976377 0.78 ALOX15 (0.37) EPHX1EP300HIF1ACREBBPALOX15
SCHEMBL27519971 0.78 ALOX15 (0.37) EPHX1EP300HIF1ACREBBPALOX15
SCHEMBL28976380 0.78 ALOX15 (0.37) EPHX1EP300HIF1ACREBBPALOX15
SCHEMBL7389756 0.76 EP300 (0.33) EP300HIF1ACREBBPALOX15
SCHEMBL7390216 0.76 EP300 (0.33) EP300HIF1ACREBBPALOX15
Hydrochloric Acid SCHEMBL29069900 0.76 MAPK1 (0.36) EPHX1EP300HIF1ACREBBPALOX15
SCHEMBL1355956 0.73 EP300 (0.31) EP300HIF1ACREBBPALOX15
SCHEMBL27470790 0.72 ALOX15 (0.32) ALOX15
SCHEMBL7387498 0.71 EP300 (0.30) EP300HIF1ACREBBP
SCHEMBL27469789 0.71 ALOX15 (0.33) ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1344245-A Inhibitors of branched chain amino acid dependent aminotransferases and their use in the treatment of diabetic retinopathy WARNER LAMBER CO (US) 2002-04-10 — — CN claimed
CN-1170811-C Inhibitors of branched chain amino acid dependent aminotransferases and their use in the treatment of diabetic retinopathy ��ʲ 2004-10-13 — — CN disclosed
CN-1344245-A Inhibitors of branched chain amino acid dependent aminotransferases and their use in the treatment of diabetic retinopathy WARNER LAMBER CO (US) 2002-04-10 — — CN disclosed
Send feedback